Assignee
TAMBO INC
US·6 granted patents·8 pending applications·8 citations·filing 2016–2025
Top patents by PatentIndex Score
14 records- 0187US11253600B2Bioorthogonal compositionsTAMBO INC·Filed 2018·Granted Feb 22, 2022·3 cites·27 claims
- 0287US10828373B2Bioorthogonal compositionsTAMBO INC·Filed 2016·Granted Nov 10, 2020·5 cites·23 claims
- 0372US12527874B2Bioorthogonal compositionsTAMBO INC·Filed 2021·Granted Jan 20, 2026·0 cites·7 claims
- 0471US2025135005A1Processes for preparing functionalized cyclooctenesTAMBO INC·Filed 2024·Application pending·0 cites
- 0568US2025255970A1Bioorthogonal compositionsTAMBO INC·Filed 2025·Application pending·0 cites
- 0667US12296017B2Bioorthogonal compositionsTAMBO INC·Filed 2021·Granted May 13, 2025·0 cites·14 claims
- 0767US2025049936A1Bioorthogonal compositionsTAMBO INC·Filed 2024·Application pending·0 cites
- 0866US2026007759A1Trans-cyclooctene prodrug of monomethyl auristatin eTAMBO INC·Filed 2025·Application pending·0 cites
- 0964US12589162B2Trans-cyclooctene prodrug of monomethyl auristatin ETAMBO INC·Filed 2021·Granted Mar 31, 2026·0 cites·4 claims
- 1061US2021015932A1Bioorthogonal compositionsTAMBO INC·Filed 2020·Application pending·0 cites
- 1159US12194100B2Processes for preparing functionalized cyclooctenesTAMBO INC·Filed 2019·Granted Jan 14, 2025·0 cites·7 claims
- 1259US2025009890A1Trans-cyclooctene-modified bispecific antibodiesTAMBO INC·Filed 2022·Application pending·0 cites
- 1355US2025186592A1Tetrazine conjugates for in vivo targeted delivery of a payloadTAMBO INC·Filed 2022·Application pending·0 cites
- 1446US2022259254A1Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapyTAMBO INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →